Disc Medicine Inc

Disc Medicine Inc

IRON

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.67B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Disc Medicine IncDisc Medicine Inc-10.5--38%-66.1-
$101.80

Target Price by Analysts

54% upsideDisc Medicine Target Price DetailsTarget Price
$2.53

Current Fair Value

96.2% downside

Overvalued by 96.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.67 Billion
Enterprise Value$2.57 Billion
Dividend Yield$- (-)
Earnings per Share$-6.01
Beta2.05
Outstanding Shares38,685,565

Return

Return on Equity-38.17%ROE
Return on Assets-33.45%
Return on Invested Capital-37.03%

Valuation & Multiples

P/E Ratio-10.53P/E Ratio
PEG-135.83PEG
Price to Sales-66.09Price to Sales
Price to Book Ratio4.13Price to Book Ratio
Enterprise Value to Revenue-129.36
Enterprise Value to EBIT-9.86
Enterprise Value to Net Income-11
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-1.71
Average shareholder expectation
Revenue Estimate
$1.00 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-1.65
Average shareholder expectation
Revenue Estimate
$1.88 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1824 3.77%
Total Calls355,800 0.25%
Total Puts64,900 16.90%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %111.22% 2.37%
Total Invested$3.15B 17.91%
Investors Holding233 24.00%

ESG Score

No data

About Disc Medicine Inc